Shanghai Junshi Biosciences Co Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.023x

Shanghai Junshi Biosciences Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shanghai Junshi Biosciences Co Ltd (688180) has a cash flow conversion efficiency ratio of -0.023x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-142.12 Million ≈ $-20.80 Million USD) by net assets (CN¥6.22 Billion ≈ $910.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shanghai Junshi Biosciences Co Ltd (2014–2025)

Cash flow conversion efficiency of Shanghai Junshi Biosciences Co Ltd from 2014 to 2025. This chart illustrates how Shanghai Junshi Biosciences Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Shanghai Junshi Biosciences Co Ltd for real-time trading data and today's change.

Shanghai Junshi Biosciences Co Ltd Cash Flow Conversion Ratio Explained

Shanghai Junshi Biosciences Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shanghai Junshi Biosciences Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Junshi Biosciences Co Ltd ranked by their cash flow conversion efficiency. Also see 688180 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Wistron NeWeb Corp TW:6285	-0.198x
National Health Investors Inc NYSE:NHI	0.035x
Lepu Medical Tech Beijing SHE:300003	0.024x
Jb Financial KO:175330	-0.117x
EO Technics Co. Ltd KQ:039030	0.007x
M/I Homes Inc NYSE:MHO	0.011x
Tegna Inc NYSE:TGNA	0.034x
Enliven Therapeutics Inc. NASDAQ:ELVN	-0.021x

Annual Cash Flow Conversion Efficiency for Shanghai Junshi Biosciences Co Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Junshi Biosciences Co Ltd from 2014 to 2025. Review Shanghai Junshi Biosciences Co Ltd (688180) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.22 Billion ≈ $910.73 Million	CN¥-478.14 Million ≈ $-69.97 Million	-0.077x	+68.32%
2024-12-31	CN¥5.95 Billion ≈ $870.71 Million	CN¥-1.44 Billion ≈ $-211.13 Million	-0.242x	+11.46%
2023-12-31	CN¥7.32 Billion ≈ $1.07 Billion	CN¥-2.00 Billion ≈ $-293.39 Million	-0.274x	-51.10%
2022-12-31	CN¥9.79 Billion ≈ $1.43 Billion	CN¥-1.78 Billion ≈ $-259.79 Million	-0.181x	-135.29%
2021-12-31	CN¥8.33 Billion ≈ $1.22 Billion	CN¥-641.90 Million ≈ $-93.93 Million	-0.077x	+69.98%
2020-12-31	CN¥5.84 Billion ≈ $854.76 Million	CN¥-1.50 Billion ≈ $-219.32 Million	-0.257x	+35.40%
2019-12-31	CN¥2.99 Billion ≈ $437.31 Million	CN¥-1.19 Billion ≈ $-173.70 Million	-0.397x	-158.27%
2018-12-31	CN¥3.32 Billion ≈ $485.99 Million	CN¥-510.76 Million ≈ $-74.74 Million	-0.154x	+50.40%
2017-12-31	CN¥1.12 Billion ≈ $163.79 Million	CN¥-347.08 Million ≈ $-50.79 Million	-0.310x	-88.62%
2016-12-31	CN¥1.13 Billion ≈ $164.86 Million	CN¥-185.21 Million ≈ $-27.10 Million	-0.164x	-23.10%
2015-12-31	CN¥614.22 Million ≈ $89.88 Million	CN¥-82.03 Million ≈ $-12.00 Million	-0.134x	-9.00%
2014-12-31	CN¥319.87 Million ≈ $46.81 Million	CN¥-39.19 Million ≈ $-5.73 Million	-0.123x	--

About Shanghai Junshi Biosciences Co Ltd

SHG:688180 China Biotechnology

Market Cap

$3.24 Billion

CN¥22.17 Billion CNY

Market Cap Rank

#4520 Global

#655 in China

Share Price

CN¥28.96

Change (1 day)

-2.95%

52-Week Range

CN¥28.93 - CN¥45.04

All Time High

CN¥151.00